Comment on "Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies" and "High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints"

被引：0
|
作者：
Kong, Leping [1 ]
Alffenaar, Jan-Willem C. [1 ,2 ,3 ]
Stocker, Sophie L. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Sydney, Fac Med & Hlth, Sch Pharm, Sydney, NSW, Australia
[2] Univ Sydney, Infect Dis Inst, Sydney, NSW, Australia
[3] Westmead Hosp, Dept Pharm, Sydney, NSW, Australia
[4] St Vincents Hosp, Dept Clin Pharmacol & Toxicol, Darlinghurst, NSW, Australia
来源：
CLINICAL PHARMACOKINETICS | 2024年 / 63卷 / 05期
关键词：
D O I：
10.1007/s40262-024-01357-4
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：731 / 733
页数：3
相关论文
共 5 条
  • [1] High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints
    Jansen, Anouk M. E.
    ter Heine, Rob
    Verweij, Paul E.
    Bruggemann, Roger J. M.
    CLINICAL PHARMACOKINETICS, 2023, 62 (12) : 1695 - 1699
  • [2] High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints
    Jansen, Anouk M. E.
    ter Heine, Rob
    Verweij, Paul E.
    Brueggemann, Roger J. M.
    CLINICAL PHARMACOKINETICS, 2023,
  • [3] High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints
    Anouk M. E. Jansen
    Rob ter Heine
    Paul E. Verweij
    Roger J. M. Brüggemann
    Clinical Pharmacokinetics, 2023, 62 : 1695 - 1699
  • [4] Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies
    Jansen, Anouk M. E.
    Mertens, Beatrijs
    Spriet, Isabel
    Verweij, Paul E.
    Schouten, Jeroen
    Wauters, Joost
    Debaveye, Yves
    ter Heine, Rob
    Bruggemann, Roger J. M.
    CLINICAL PHARMACOKINETICS, 2023, 62 (12) : 1701 - 1711
  • [5] Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies
    Anouk M. E. Jansen
    Beatrijs Mertens
    Isabel Spriet
    Paul E. Verweij
    Jeroen Schouten
    Joost Wauters
    Yves Debaveye
    Rob ter Heine
    Roger J. M. Brüggemann
    Clinical Pharmacokinetics, 2023, 62 : 1701 - 1711
1